Cita APA (7a ed.)

Helsen, C. W., Hammill, J. A., Lau, V. W. C., Mwawasi, K. A., Afsahi, A., Bezverbnaya, K., . . . Bramson, J. L. (2018). The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity. Nature Portfolio.

Cita Chicago Style (17a ed.)

Helsen, Christopher W., et al. The Chimeric TAC Receptor Co-opts the T Cell Receptor Yielding Robust Anti-tumor Activity Without Toxicity. Nature Portfolio, 2018.

Cita MLA (8a ed.)

Helsen, Christopher W., et al. The Chimeric TAC Receptor Co-opts the T Cell Receptor Yielding Robust Anti-tumor Activity Without Toxicity. Nature Portfolio, 2018.